CLINICAL_TRIALS
trial_result
· 2025-04-08
Clinical Trial Update: Ketamine for OUD and Suicidal Ideation in the ED [Phase 2]
Summary
A Phase 2 trial evaluating ketamine for opioid use disorder and suicidal ideation in the emergency department has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Opioid Use Disorder, Suicidal Ideation | Phase 2 | Status: TERMINATED